Given that immunogenicity to biologics may contribute to IBD treatment failure, the study authors sought to determine the rate of ADA formation to individual biologic agents.
PillCam SB3 @HOME offers a telehealth option for direct visualization and monitoring of the small intestine.
The interchangeable biosimilar product may be substituted for the reference product by a pharmacist.
The application is supported by data from two phase 3 induction studies (ADVANCE and MOTIVATE) and one phase 3 maintenance study (FORTIFY).
Investigators assessed trends in corticosteroid use in patients with IBD over a period of 20 years.
Rate of symptomatic remission at week 6 similar for Mediterranean diet, specific carbohydrate diet in randomized trial
Anti-TNFα recommended over no treatment for induction and maintenance of remission for adult outpatients
Patients with IBD were compared to control groups without IBD, which included 14 completely vaccinated healthcare workers and 29 vaccinated healthy volunteers.
More research and follow-up on infliximab is needed to determine the appropriate length of treatment and who will benefit most from treatment.
Although the definition of remission varies, the goal of IBD treatment is to achieve and sustain remission.
